Skip to content

Research on the application of ultrasound-guided regional block technique in enhanced recovery

A comparative study of the efficacy of ropivacaine bone nerve block with different concentrations and intra-articular injection on pain after hip arthroscopy

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091579
Enrollment
Unknown
Registered
2024-10-30
Start date
2024-06-03
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain

Interventions

Control:General anesthesia plus intra-articular local injection anesthesia after surgery
0.5% ropivacaine FNB group:General anesthesia plus 0.5% ropivacaine preoperative femoral nerve block anesthesia
0.6% ropivacaine FNB group:General anesthesia plus 0.6% ropivacaine preoperative femoral nerve block anesthesia

Sponsors

The Red Cross Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) American Society of Anesthesiologists (ASA) classifications I through III; (2) between the ages of 18 and 65; (3) Body mass index BMI less than 35Kg/m2; (4) Patients with clear hip labral injury or hip impingement syndrome; (5) Complete clinical data; (6) The postoperative follow-up time = 4 months.

Exclusion criteria

Exclusion criteria: (1) Patients with other hip injuries who cannot undergo arthroscopic surgery; (2) Accompanied by vascular and nerve damage; (3) with severe medical comorbidities; (4) Those who cannot complete the follow-up or withdraw halfway; (5) Those who are unable or unwilling to provide informed consent and substance abuse.

Design outcomes

Primary

MeasureTime frame
VAS score;Opioid consumption;

Secondary

MeasureTime frame
Rasmay score;Postoperative ambulation ;

Countries

China

Contacts

Public ContactLi Zhang

The Red Cross Affiliated Hospital of Xi'an Jiaotong University

398018271@qq.com+86 159 0290 8060

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026